{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:08:42Z","timestamp":1793286522735,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejmech.2024.116434","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T05:58:00Z","timestamp":1713592680000},"page":"116434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Probing benzenesulfonamide\u2013thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: \u03b1-glucosidase and carbonic anhydrase II"],"prefix":"10.1016","volume":"271","author":[{"given":"Mona A.","family":"Gamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-6928","authenticated-orcid":false,"given":"Samar H.","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa A.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaneya S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116434_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115270","article-title":"Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl) alkanoic acids active as novel dual-targeted PTP1B\/AKR1B1 inhibitors","volume":"252","author":"Maccari","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.02.072","article-title":"Synthesis, molecular modeling and evaluation of \u03b1-glucosidase inhibition activity of 3, 4-dihydroxy piperidines","volume":"150","author":"Kasturi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108220","article-title":"Extending the investigation of 4-thiazolidinone derivatives as potential multi-target ligands of enzymes involved in diabetes mellitus and its long-term complications: a study with pancreatic \u03b1-amylase","volume":"499","author":"Szab\u00f3","year":"2021","journal-title":"Carbohydr. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116434_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/molecules26020330","article-title":"In search for Multi-Target ligands as potential agents for diabetes mellitus and its complications\u2014a structure-activity relationship study on inhibitors of aldose reductase and protein tyrosine phosphatase 1B","volume":"26","author":"Ottan\u00e0","year":"2021","journal-title":"Molecules"},{"issue":"Supplement_1","key":"10.1016\/j.ejmech.2024.116434_bib5","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2024.116434_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2019.04.025","article-title":"Synthetic heterocyclic candidates as promising \u03b1-glucosidase inhibitors: an overview","volume":"176","author":"Dhameja","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib7","series-title":"Diabetes: an Old Disease, a New Insight","first-page":"1","article-title":"Introduction to diabetes mellitus","author":"Kaul","year":"2013"},{"key":"10.1016\/j.ejmech.2024.116434_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fphar.2020.00215","article-title":"Hepatic glucose output inhibition by Mexican plants used in the treatment of type 2 diabetes","volume":"11","author":"Mata-Torres","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116434_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.11613\/BM.2013.033","article-title":"Diabetes and beta cell function: from mechanisms to evaluation and clinical implications","volume":"23","author":"Cernea","year":"2013","journal-title":"Biochem. Med."},{"key":"10.1016\/j.ejmech.2024.116434_bib10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11011-021-00839-9","article-title":"The role of carbonic anhydrase III and autophagy in type 2 diabetes with cardio-cerebrovascular disease","volume":"36","author":"Zhang","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116434_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/jdi.12711","article-title":"Meta\u2010analysis and critical review on the efficacy and safety of alpha\u2010glucosidase inhibitors in Asian and non\u2010Asian populations","volume":"9","author":"Gao","year":"2018","journal-title":"Journal of diabetes investigation"},{"key":"10.1016\/j.ejmech.2024.116434_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105046","article-title":"Synthesis of novel 5-(2, 5-bis (2, 2, 2-trifluoroethoxy) phenyl)-1, 3, 4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors","volume":"114","author":"Gani","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib13","article-title":"Discovery of triazole tethered thymol\/carvacrol-coumarin hybrids as new class of \u03b1-glucosidase inhibitors with potent in vivo antihyperglycemic activities","author":"Singh","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib14","article-title":"Synthesis and biological evaluation of indole derivatives containing thiazolidine-2, 4-dione as \u03b1-glucosidase inhibitors with antidiabetic activity","author":"Hu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2165\/00003495-198835030-00003","article-title":"Acarbose: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential","volume":"35","author":"Clissold","year":"1988","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116434_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2165\/00003495-200059030-00012","article-title":"Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus","volume":"59","author":"Scott","year":"2000","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.ejmech.2024.116434_bib17","first-page":"3023","article-title":"Voglibose: an alpha glucosidase inhibitor","volume":"7","author":"Dabhi","year":"2013","journal-title":"J. Clin. Diagn. Res.: J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejmech.2024.116434_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/9781119785033.ch11","article-title":"Acarbose and alpha glucosidase inhibitors","author":"Fisher","year":"2022","journal-title":"Diabetes Drug Notes"},{"key":"10.1016\/j.ejmech.2024.116434_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejmech.2019.05.045","article-title":"Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: \u03b1-Glucosidase inhibition and glucose uptake promotion","volume":"177","author":"Ye","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116434_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jhet.3777","article-title":"Synthesis and antibacterial activity of a series of 2\u2010trifluoromethylbenzimidazole\u2010thiazolidinone derivatives","volume":"57","author":"Cheddie","year":"2020","journal-title":"J. Heterocycl. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116434_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.12991\/mpj.2018.61","article-title":"Synthesis and antiviral activity evaluation of new 4-thiazolidinones bearing an imidazo [2, 1-b] thiazole moiety","volume":"22","author":"Guzeldemirci","year":"2018","journal-title":"Marmara Pharm. J."},{"key":"10.1016\/j.ejmech.2024.116434_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bioorg.2017.02.007","article-title":"Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains","volume":"71","author":"Suryawanshi","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejmech.2017.12.049","article-title":"Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: targeting human carbonic anhydrase IX","volume":"144","author":"Ansari","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104827","article-title":"Design, synthesis and molecular docking of new pyrazole-thiazolidinones as potent anti-inflammatory and analgesic agents with TNF-\u03b1 inhibitory activity","volume":"111","author":"Abd El-Karim","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2024.116434_bib25","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1080\/00397911.2021.1946699","article-title":"5-Benzylidene-2, 3-diarylthiazolidine-4-ones: design, synthesis, spectroscopic characterization, in vitro biological and computational evaluation","volume":"51","author":"Saeedian Moghadam","year":"2021","journal-title":"Synth. Commun."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116434_bib26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jhet.3514","article-title":"Thiazolidinones: synthesis, reactivity, and their biological applications","volume":"56","author":"Nirwan","year":"2019","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib27","series-title":"Synthesis, in Vitro \u03b1-glucosidase and \u03b1-amylase Activities, and an in Silico Molecular Docking Study of Triazinoindole-Thiazolidinone Hybrid","author":"Khan","year":"2023"},{"issue":"10","key":"10.1016\/j.ejmech.2024.116434_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3390\/ph15101164","article-title":"Design, synthesis, in silico testing, and in vitro evaluation of thiazolidinone-based benzothiazole derivatives as inhibitors of \u03b1-amylase and \u03b1-glucosidase","volume":"15","author":"Khan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116434_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133812","article-title":"Synthesis, in vitro \u03b1-amylase, \u03b1-glucosidase activities and molecular docking study of new benzimidazole bearing thiazolidinone derivatives","volume":"1269","author":"Khan","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116434_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900304","article-title":"Synthesis, characterization, biological evaluation, and molecular docking studies of some piperonyl\u2010based 4\u2010thiazolidinone derivatives","volume":"353","author":"Gen\u00e7 Bilgi\u00e7li","year":"2020","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2024.116434_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129411","article-title":"A simple yet multifaceted 90 years old, evergreen enzyme: carbonic anhydrase, its inhibition and activation","volume":"93","author":"Supuran","year":"2023","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116434_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijbiomac.2020.11.170","article-title":"Utilization of the common functional groups in bioactive molecules: exploring dual inhibitory potential and computational analysis of keto esters against \u03b1-glucosidase and carbonic anhydrase-II enzymes","volume":"167","author":"Khan","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116434_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1573399812666161214122351","article-title":"The role of carbonic anhydrase in hepatic glucose production","volume":"14","author":"Ismail","year":"2018","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.ejmech.2024.116434_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2014.03.023","article-title":"New aminobenzenesulfonamide\u2013thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies","volume":"78","author":"Zaib","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"196","key":"10.1016\/j.ejmech.2024.116434_bib35","article-title":"Carbonic anhydrase: a new therapeutic target for managing diabetes","volume":"5","author":"Ibrahim","year":"2016","journal-title":"J. Metab. Syndrome"},{"issue":"14","key":"10.1016\/j.ejmech.2024.116434_bib36","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116434_bib37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/13543776.2023.2245971","article-title":"Targeting carbonic anhydrases for the management of hypoxic metastatic tumors","volume":"33","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2024.116434_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103897","article-title":"Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1, 3, 5-triazine structural motifs","volume":"100","author":"Lolak","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","article-title":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: selective inhibitors for the tumor-associated hCA IX isoform","volume":"152","author":"Ibrahim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116434_bib40","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1, 3, 5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116434_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115329","article-title":"New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies","volume":"28","author":"Abdel-Mohsen","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116434_bib42","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.bmc.2017.01.008","article-title":"Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties","volume":"25","author":"Altug","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2022.100967","article-title":"New thiazole-based thiazolidinone derivatives: synthesis, in vitro \u03b1-amylase, \u03b1-glucosidase activities and silico molecular docking study","volume":"42","author":"Khan","year":"2022","journal-title":"Chemical Data Collections"},{"key":"10.1016\/j.ejmech.2024.116434_bib44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bioorg.2018.01.031","article-title":"Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors","volume":"77","author":"Mahmood","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116434_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1021\/ja01217a042","article-title":"The preparation of sulfanilamide derivatives containing a urea or thiourea grouping","volume":"67","author":"Roth","year":"1945","journal-title":"J. Am. Chem. Soc."},{"issue":"40","key":"10.1016\/j.ejmech.2024.116434_bib46","doi-asserted-by":"crossref","first-page":"19043","DOI":"10.1039\/D1NJ02862F","article-title":"Novel coumarin\u2013pyrazoline hybrids: synthesis, cytotoxicity evaluation and molecular dynamics study","volume":"45","author":"Ragab","year":"2021","journal-title":"New J. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116434_bib47","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bmc.2008.10.032","article-title":"Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach","volume":"17","author":"Bhandari","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103577","article-title":"New benzenesulfonamide scaffold-based cytotoxic agents: design, synthesis, cell viability, apoptotic activity and radioactive tracing studies","volume":"96","author":"Nissan","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116434_bib49","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/14756366.2019.1654470","article-title":"Exploring new structural features of the 4-[(3-methyl-4-aryl-2, 3-dihydro-1, 3-thiazol-2-ylidene) amino] benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases","volume":"34","author":"Distinto","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116434_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/14756366.2016.1235042","article-title":"Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors","volume":"32","author":"Melis","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116434_bib52","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase: I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106844","article-title":"Design, synthesis, biological evaluation, and docking study of new triazole-phenylacetamide derivatives as \u03b1-glucosidase inhibitors","volume":"141","author":"Luo","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2024.116434_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2024.116434_bib55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","article-title":"Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: selective inhibitors of hCA IX","volume":"179","author":"Allam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"26","key":"10.1016\/j.ejmech.2024.116434_bib56","doi-asserted-by":"crossref","first-page":"19296","DOI":"10.1074\/jbc.M113.465211","article-title":"Molecular basis for the recognition of long-chain substrates by plant \u03b1-glucosidases","volume":"288","author":"Tagami","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116434_bib57","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1107\/S1744309109036665","article-title":"High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design","volume":"65","author":"Sippel","year":"2009","journal-title":"Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun."},{"issue":"17","key":"10.1016\/j.ejmech.2024.116434_bib58","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116434_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116434_bib60","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A boiled\u2010egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116434_bib61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bioorg.2018.10.025","article-title":"Novel hybrids of benzothiazole-1, 3, 4-oxadiazole-4-thiazolidinone: synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment","volume":"83","author":"Bhutani","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bioorg.2018.03.022","article-title":"Synthesis, in vitro \u03b1-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs","volume":"78","author":"Javid","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib63","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib64","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib65","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/14756366.2020.1755852","article-title":"Bacterial \u03b9-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii","volume":"35","author":"Del Prete","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib66","series-title":"Schr\u00f6dinger Suite Release 2022-2","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116434_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111642","article-title":"From random to rational: a discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction","volume":"182","author":"Kalinin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116434_bib68","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2024.116434_bib69","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2024.116434_bib70","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1021\/acsmedchemlett.3c00094","article-title":"Discovery of novel hydroxyimine-tethered benzenesulfonamides as potential human carbonic anhydrase IX\/XII inhibitors","volume":"14","author":"Peerzada","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116434_bib71","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:35:26Z","timestamp":1717234526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":71,"alternative-id":["S0223523424003143"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116434","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing benzenesulfonamide\u2013thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: \u03b1-glucosidase and carbonic anhydrase II","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116434"}}